Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy

Thursday, April 06, 2017 | Personnel/Company News , Allergan


Daphne Karydas is Allergan’s new Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017.  

In this role, Ms. Karydas will lead the Company's engagement with the investment community, and will work with the Company's Executive Leadership Team to develop and execute the Company's long-term business strategy. Ms. Karydas will report to Tessa Hilado, Chief Financial Officer of Allergan.

Ms. Karydas has more than 16 years of industry experience as a leading institutional investor and financial analyst in the biopharmaceutical sector, most recently at J.P. Morgan Asset Management. Previously, she was a healthcare Equity Research Analyst and Portfolio Manager at The Boston Company Asset Management, a Bank of New York Mellon company. Before joining The Boston Company, Ms. Karydas was a Vice President at Goldman Sachs where she worked in the Investment Banking Division as well as Goldman Sachs Asset Management focused on healthcare companies. Earlier in her career, she was a Project Chemical Engineer at Merck & Co. in the Vaccines division where she focused on process development for novel vaccines.

Ms. Karydas holds a B.A. and M.S. in chemical engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.

 

 

 

Next Story

Comments

You must be logged in to leave a comment.